Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis

@article{Hiles2019DoesMA,
  title={Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis},
  author={Sarah A. Hiles and Vanessa Marie McDonald and Michelle C Guilhermino and Guy G. Brusselle and Peter G. Gibson},
  journal={European Respiratory Journal},
  year={2019},
  volume={54}
}
Background Preventing exacerbations is an important goal of asthma treatment. Long-term treatment with azithromycin may help achieve this. Our aim was to conduct a systematic review and individual participant data (IPD) meta-analysis to examine the efficacy of azithromycin in reducing exacerbations in asthma, and in the subphenotypes of noneosinophilic asthma, eosinophilic asthma and severe asthma. Method We completed a systematic search of Embase, MEDLINE, PubMed, Cochrane Library… 
Macrolides versus placebo for chronic asthma.
TLDR
The evidence suggests macrolides probably deliver a moderately sized reduction in exacerbations requiring hospitalisations compared to placebo, and for both the ACQ and the AQLQ the suggested effect of macrolide versus placebo did not reach a minimal clinically important difference.
Cost-utility of azithromycin in patients with severe asthma.
TLDR
Add-on therapy with azithromycin was found to be cost-effective when added to usual care in patients who remain uncontrolled despite treatment with medium or high-dose ICS/LABA.
Outcomes of Antibiotics in Adults with “Difficult to Treat” Asthma or the Overlap Syndrome
TLDR
Antibiotic treatment may be beneficial in a significant proportion of “difficult to treat” asthma patients beyond one year, including some patients with the overlap syndrome and/or who fail to meet criteria for refractoriness.
The Patients’ Experience of Severe Asthma Add-On Pharmacotherapies: A Qualitative Descriptive Study
TLDR
Patients with severe asthma experience vast improvements in quality-of-life and life participation with add-on therapies, but there remains a significant burden related to oral corticosteroids and incomplete treatment responses.
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
TLDR
Across all age groups and levels of severity, regular personalized assessment, treatment of modifiable risk factors, self-management education, skills training, appropriate medication adjustment, and review remain essential to optimize asthma outcomes.
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
TLDR
Across all age groups and levels of severity, regular personalized assessment, treatment of modifiable risk factors, self-management education, skills training, appropriate medication adjustment, and review remain essential to optimize asthma outcomes.
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
TLDR
If implemented, OCS stewardship can ensure that clinicians and patients with asthma are aware that OCS should not be used lightly, while providing reassurance that asthma can be controlled in most people without frequent use of OCS.
Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids
TLDR
Antibiotic therapy may be associated with a longer hospital length of stay, higher hospital cost, and similar risk of treatment failure, and the need to reduce inappropriate antibiotic prescribing among patients hospitalized for asthma is highlighted.
...
...

References

SHOWING 1-10 OF 33 REFERENCES
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
TLDR
Azithromycin was well tolerated, but was associated with increased oropharyngeal carriage of macrolide-resistant streptococci, and a significant reduction in the PEP rate in azithromyzin-treated patients with non-eosinophilic severe asthma warrants further study.
Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies
TLDR
Moderate-quality evidence supports long-term antibiotic therapy for preventing exacerbations in stable non-CF bronchiectasis including prevention of exacerbations.
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials
TLDR
Prophylactic antibiotics were effective in preventing COPD exacerbations and improving quality of life among stable patients with moderate to severe COPD.
Antibiotics for exacerbations of asthma.
TLDR
To determine the efficacy and safety of antibiotics in the treatment of asthma exacerbations, the Cochrane Airways Trials Register was searched for records compiled from multiple electronic and handsearched resources and six studies met the inclusion criteria.
Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
TLDR
Clarithromycin therapy can modulate IL-8 levels and neutrophil accumulation and activation in the airways of patients with refractory asthma and may be an important additional therapy that could be used to reduce noneosinophilic airway inflammation, particularly neutrophilic inflammation, in asthma.
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
TLDR
Investigation of the onset of adverse outcomes beginning at SCS initiation in a broad asthma population suggests urgent need for reappraisal of when patients need specialist care and consideration of nonsteroid therapy.
Adverse events in people taking macrolide antibiotics versus placebo for any indication.
TLDR
The incidences of reported adverse events in people taking macrolide antibiotics compared to placebo for any indication were quantified to quantify the risk of bias and the quality of evidence for each outcome of interest.
The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
TLDR
Macrolides influence a broad range of immunological mechanisms resulting in immunomodulatory effects and to optimize the treatment of chronic inflammatory diseases by macrolides, further studies are necessary, particularly comparing different macrolide and dose effect relationships.
...
...